Kandera Reinhard 4
4 · HOOKIPA Pharma Inc. · Filed Apr 20, 2022
Insider Transaction Report
Form 4
Kandera Reinhard
DirectorChief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-04-19+92,950→ 92,950 totalExercise: $1.66Exp: 2032-04-19→ Common Stock (92,950 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on April 19, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.